Adult

Experiencing emotional pain is a necessary part of life. Emotional pain often contains valuable lessons to help us on our journeys. We need to make sure we are not numbing our hearts to those that are hurting. We need to de-stigmatize the struggles, joys and pains that come with being human. We need to not just mindlessly pursue happiness - though we might think of that as an inalienable right - and avoid pain. We need to do the only thing that brings true joy: embrace all of life and each other, as we experience together all that makes us human.

This week another study was published showing that SSRI antidepressant use during pregnancy is associated with increased rates of autism in the children.  By my count, this is now the tenth study on this topic and it follows on the heels of previous studies – all of which found links between SSRI antidepressant use in pregnancy and autism in the offspring.  Most of these studies were recently reviewed by Man, et al, who also concluded that SSRI antidepressant use during pregnancy is associated with autism in the children. So we now have numerous studies in different human populations all showing a link between SSRI use in pregnancy and autism in the children. Yet, much of the news and blogosphere focus on casting doubts about these findings. What is going on here?

Recent meta-analyses of antidepressant clinical trials have revealed that up to 82% of the effects associated with the drugs may be attributed to placebo and non-medication factors. A new study examined the attitudes of psychiatrists toward these non-pharmacologic factors and found a large discrepancy between their beliefs and the empirical evidence.

"What was going on inside Turning Point was an experiment: a community-based treatment center designed to serve low-income African-Americans. After a few bumpy early...

“Therapists and other people who help victims of trauma can become traumatized themselves.” Aaron Reuben writes in The Atlantic. “Hearing stories of suffering, in other words, can generate more suffering.”

“Offenders sentenced to forensic psychiatric care do not consider their mental illness to be the main reason for their crime. Instead, they point to abuse, poverty or anger toward a particular person.”

In a series of experiments in mice, researchers found that the drug risperidone alters gut microbes, which in turn profoundly influence metabolism, weight, and overall health.

In Scientific American, Kasley Killam presents insights from research on “post-traumatic growth,” highlighting the importance of finding meaning or underlying significance in our struggles and misery. “The psychiatrist and Holocaust survivor Viktor Frankl wrote extensively about this process after observing that his fellow inmates in concentration camps were more likely to survive the horrific conditions if they held on to a sense of meaning.”

The Daily Telegraph reports on a warning published in the Medical Journal of Australia that urges doctors not to “jump the gun in prescribing patients the drug ketamine to treat depression.”

An analysis of medical records in the UK reveals that the use of certain antidepressants for depression is linked to a heightened risk for mania and bipolar disorder. The research, published this week in BMJ Open, found the strongest effect for serotonin reuptake inhibitors (SSRIs) and the antidepressant venlafaxine.

A former pharma executive has broken ranks with the industry in a new book by reporting how multiple psychiatrists, schools, and his desperate hopes pressed him to allow higher and higher doses of antipsychotic medications. The result: his 15-year-old son's death from Seroquel.

Critical psychiatry researcher, anthropologist and NYU professor Helena Hansen writes: “Opioid maintenance acts as a kind of pharmaceutical prosthesis which promises to return white ‘addicts’ to regaining their status as full human persons and middle-class consumers. Meanwhile, black and brown users are not deemed as persons to be rescued, but rather dangerous subjects to be pharmaceutically contained within the public discipline of the state.”

In a major study, published yesterday in JAMA Pediatrics, the use of SSRI antidepressants during pregnancy was found to increase the risk of autism spectrum disorder (ASD) by 87-percent. Previous studies reveal that more than 13-percent of women currently use SSRI antidepressants during pregnancy.

“Some autistic adults have spent much of their lives with the wrong diagnosis, consigned to psychiatric institutions or drugged for disorders they never had,” Jessica Wright writes in The Atlantic.

Psychologist William Copeland writes for Mental Health Recovery that “bullying can occur at any age and the effects of which remain harmful long after the behavior has been endured.” “We, as a society, are just beginning to understand and come to terms with the havoc that bullying wreaks on the emotional lives of its victims.

A new study in JAMA reveals that, on average, 25% of beginning physicians meet the diagnostic criteria for major depression. In an accompanying editorial, Dr. Thomas Schwenk, added: "Everybody asks me, because of some of my prior studies, should we have more intense work in diagnosing depression in students? Of course, the answer is 'yes,' but how do you go about that without further stigmatizing them, further labeling them, further singling them out to even greater stigma? It's not just an issue of, 'Let's make better diagnoses and let's provide better treatment'; it’s more complicated than that."

A phase 1 study for a stem cell derived agent that promotes the growth of new nerve cells in the brain demonstrated efficacy in a very small sample of patients diagnosed with major depressive disorder (MDD). The phase 1B study was published online December 8 in Molecular Psychiatry.

Citing a 43 percent jump since 2003, researchers estimate that 5.8 million school-aged children and teens in the US now have an ADHD diagnosis, a staggering 12 percent of this population. The new NIH-funded analysis also found that the percentage of girls diagnosed with ADHD was up 55% and that the percentage of Hispanic children diagnosed shot up 83% over the same timeframe.

A new study, published this week in BMJ, found no major differences in the effectiveness of cognitive behavioral therapy (CBT) and antidepressants. When the researchers compared previous studies, they found no major differences in relapse rates or level of treatment response between those taking antidepressants and those undergoing CBT.

A four-part series from Canada Free Press on Pfizer’s smoking cessation drug Chantix and its connection to violence and suicide. “The 26 case reports included three actual suicides. In every case, the acts or thoughts of violence towards others appeared to be both unprovoked and inexplicable. Most of the perpetrators had no previous history of violence, and most of them were middle-aged women—not a group known for its propensity towards violent behavior.”

A new pro-recovery manualized intervention – called the REFOCUS intervention – has been developed and will now be evaluated in a multisite randomized control trials. The strengths-based intervention, which focuses on promoting relationships, is outlined in the latest issue of the British Journal of Psychiatry.

A new poll, published in the Washington Post, explores the public’s connection to prescription pain killer abuse. “A surprising 56 percent of the public say...

According to a study published in this month’s British Journal of Psychiatry, people diagnosed with depression in high-income countries are more likely to limit...

Eugene Raikhel reveals ads from 1966 where Ritalin, now prescribed largely for ADHD, was marketed as a “kind of mind antidepressant for housewives.”  “I...

“The National Women’s Health Network launched the 'Pass on the Pink Pill – Or Pass Out' campaign, to warn women of the marginal benefits...